Results 11 to 20 of about 932,176 (296)
Platelet count and platelet indices in women with preeclampsia
Vascular Health and Risk Management, 2016 Muneera A AlSheeha,1 Rafi S Alaboudi,1 Mohammad A Alghasham,1 Javed Iqbal,2 Ishag Adam1 1Department of Obstetrics and Gynaecology, College of Medicine, Qassim University, Buriadah, 2Department of Obstetrics and Gynecology, Maternity and Children’s ...
AlSheeha MA +4 more
doaj +6 more sources
Haematologica, 2014 After Giulio Bizzozero identified platelets at the end of the 19th century,[1][1] many authors sought to define the normal concentration of these elements in human blood. However, methods to enumerate platelets remained inaccurate until the middle of the last century, and the proposed ...
Carlo L. Balduini, Patrizia Noris
doaj +4 more sources
International Journal of Nephrology and Renovascular Disease, 2016 Kiyomi Koike,1,2 Kei Fukami,1 Atsushi Kawaguchi,2 Kazumasa Shimamatsu,3 Sho-ichi Yamagishi,4 Seiya Okuda1 1Division of Nephrology, Department of Medicine, Kurume University School of Medicine, Kurume, 2The Biostatistics Center, Kurume University, Kurume,
Koike K +5 more
doaj +1 more source
Association between platelet count and 30-day mortality in community-acquired pneumonia patients receiving systemic glucocorticoids therapy [PDF]
Scientific ReportsPlatelet count is a readily available hematological parameter that has been recognized as a potential indicator of inflammation and thrombosis. However, previous research has not examined the prognostic significance of platelet count in patients with ...
Congfeng Li +4 more
doaj +2 more sources
Lipolysis generates platelet dysfunction after in vivo heparin administration [PDF]
, 2002 Heparin, when administered to patients undergoing operations using cardiopulmonary bypass, induces plasma changes that gradually impair platelet macroaggregation, but heparinization of whole blood in vitro does not have this effect.
Day, S. +3 more
core +8 more sources
Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag
JHEP Reports, 2021 Background & Aims: Despite limitations, platelet transfusion has been used to minimise bleeding risk in patients with thrombocytopaenia. Lusutrombopag is an oral, thrombopoietin receptor agonist approved for treatment of thrombocytopaenia associated ...
Robert S. Brown, Jr. +7 more
doaj +1 more source
Applied Sciences, 2020 Impedance aggregometry (Multiplate®) detects the effects of platelet aggregation inhibitors and can predict thrombotic complications after coronary and cerebrovascular stent interventions.
Mohamed Soliman, Matthias Hartmann
doaj +1 more source
Recovery of Platelet Count among Apheresis Platelet Donors [PDF]
Journal of Clinical and Diagnostic Research, 2016 Introduction: Increase in awareness regarding use of single donor platelets and the availability of technology has resulted in increased platelet pheresis procedures.
Ravindra Prasad Thokala +3 more
doaj +1 more source
Decreased platelet count in patients receiving continuous veno-venous hemofiltration: a single-center retrospective study. [PDF]
PLoS ONE, 2014 BACKGROUND: A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). We aim to investigate the incidence of decreased platelet count and related risk factors in patients receiving
Buyun Wu +5 more
doaj +1 more source
Pathophysiological mechanisms leading to low platelet count in immune thrombocytopenia [PDF]
, 2020 Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by the decrease in peripheral blood platelet count below 100 x 109/L, and an increased bleeding risk when thrombocytopenia drops below 30 x 109/L. The mechanisms leading to ITP
Goette, Nora Paula +2 more
core +1 more source